Medicine
Indium DTPA In 111 1 mCi/mL injection
Indium DTPA In 111 1 mCi/mL injection is a prescription medicine containing Indium in-111 pentetate for intrathecal use, marketed by GE Healthcare, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Do not freeze. Store vial in its lead shield at a temperature of 5°-30°C…
Key facts
- Active ingredient (INN)
- Indium in-111 pentetate
- Brand
- Indium DTPA In 111
- Strength
- 1 mCi/mL
- Dosage form
- Injection
- Route
- Intrathecal
- Packs
- 1.5 mL
- Marketing authorisation holder
- GE Healthcare
- Manufacturer
- GE Healthcare
- Origin register
- US FDA, United States
- Storage
- Do not freeze. Store vial in its lead shield at a temperature of 5°-30°C (41°-86°F).
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 18 February 1982
- Identifiers
- DailyMed set ID 4fea5871-b515-4f69-a297-11507ddd7817NDC 17156-251Application NDA017707
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 1.5 mL in 1 vial, glass | 17156-251-08 | GE Healthcare | 18 February 1982 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 18 February 1982 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Clinical summary
Indium in-111 pentetate is a radioactive diagnostic agent. It is available as injection for intrathecal use. MedsAcross supplies Indium in-111 pentetate for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about Indium in-111 pentetateFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Indium DTPA In 111 prescribing information (GE Healthcare) · U.S. National Library of Medicine, DailyMed
Need Indium DTPA In 111 1 mCi/mL injection for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.